Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of interleukin-12 and/or interleukin-23 for the treatment of psoriasis: What is the evidence for an effect on malignancy?
Elizabeth N. Ergen, Nabiha Yusuf
Experimental Dermatology (2018) Vol. 27, Iss. 7, pp. 737-747
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Tyrosine kinase 2 and Janus kinase‒signal transducer and activator of transcription signaling and inhibition in plaque psoriasis
James G. Krueger, Iain B. McInnes, Andrew Blauvelt
Journal of the American Academy of Dermatology (2021) Vol. 86, Iss. 1, pp. 148-157
Open Access | Times Cited: 77
Ustekinumab for Refractory Colitis Associated with Immune Checkpoint Inhibitors
Anusha Shirwaikar Thomas, Weijie Ma, Yinghong Wang
New England Journal of Medicine (2021) Vol. 384, Iss. 6, pp. 581-583
Open Access | Times Cited: 76
Cancer and Autoimmune Diseases: A Tale of Two Immunological Opposites?
Zeev Elkoshi
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 36
Novel Therapies in Plaque Psoriasis: A Review of Tyrosine Kinase 2 Inhibitors
George Martin
Dermatology and Therapy (2023) Vol. 13, Iss. 2, pp. 417-435
Open Access | Times Cited: 21
Chemerin in inflammatory diseases
Xin Su, Ye Cheng, Guo‐Ming Zhang, et al.
Clinica Chimica Acta (2021) Vol. 517, pp. 41-47
Closed Access | Times Cited: 40
Adherence and Persistence to Biological Drugs for Psoriasis: Systematic Review with Meta-Analysis
Eugenia Piragine, Davide Petri, Alma Martelli, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 6, pp. 1506-1506
Open Access | Times Cited: 25
Cancer risk in patients with psoriasis: should we be paying more attention?
Nikolai Loft, Sofie Vaengebjerg, Lone Skov
Expert Review of Clinical Immunology (2020) Vol. 16, Iss. 5, pp. 479-492
Closed Access | Times Cited: 38
Nivolumab-induced psoriasis successfully treated with risankizumab-rzaa in a patient with stage III melanoma
George D. Glinos, William S. Fisher, Claudia Morr, et al.
JAAD Case Reports (2021) Vol. 11, pp. 74-77
Open Access | Times Cited: 24
The role of interleukin-17 and interleukin-23 inhibitors in the development, progression, and recurrence of cancer: A systematic review
Marie Vangilbergen, Aline Stockman, Axelle Van De Velde, et al.
JAAD International (2024) Vol. 17, pp. 71-79
Open Access | Times Cited: 3
Clinical application of serum biomarkers for detecting and monitoring of chronic plaque psoriasis
Criselda Jean G. Cruz, Chao‐Chun Yang
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 7
Tildrakizumab: A Review in Moderate-to-Severe Plaque Psoriasis
James E. Frampton
American Journal of Clinical Dermatology (2019) Vol. 20, Iss. 2, pp. 295-306
Closed Access | Times Cited: 20
Anti-Inflammatory Polymeric Nanoparticles Based on Ketoprofen and Dexamethasone
Eva Espinosa‐Cano, María Rosa Aguilar, Yadileiny Portilla, et al.
Pharmaceutics (2020) Vol. 12, Iss. 8, pp. 723-723
Open Access | Times Cited: 20
Effect of Melatonin on Psoriatic Phenotype in Human Reconstructed Skin Model
Sarah Adriana Scuderi, Laura Cucinotta, Alessia Filippone, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 752-752
Open Access | Times Cited: 12
Immunogenicity to biological drugs in psoriasis and psoriatic arthritis
Fernando Valenzuela, Rodrigo Flores
Clinics (2021) Vol. 76, pp. e3015-e3015
Open Access | Times Cited: 15
Unmet Challenges in Patients with Crohn’s Disease
Katharina M. Scheurlen, Mary Parks, Anne Macleod, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5595-5595
Open Access | Times Cited: 6
A Route for Investigating Psoriasis: From the Perspective of the Pathological Mechanisms and Therapeutic Strategies of Cancer
Xingkang Wu, Yushuang Ma, Lu Wang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14390-14390
Open Access | Times Cited: 6
A Transcriptome-Wide Analysis of Psoriasis: Identifying the Potential Causal Genes and Drug Candidates
Yeonbin Jeong, Jaeseung Song, Yubin Lee, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11717-11717
Open Access | Times Cited: 4
IL-23 inhibitor treatment of immune checkpoint inhibitor-associated psoriasis: case series and review of literature
Natalie Bourand, Drew Kuraitis, Bethany Lema, et al.
JAAD Case Reports (2024) Vol. 56, pp. 33-37
Open Access | Times Cited: 1
Optimization of psoriasis mouse models
Christina Karamani, Ivi Antoniadou, A. Dimou, et al.
Journal of Pharmacological and Toxicological Methods (2021) Vol. 108, pp. 107054-107054
Open Access | Times Cited: 10
Chemerin activity in selected pathological states of human body – A systematic review
Magdalena Acewicz, Irena Kasacka
Advances in Medical Sciences (2021) Vol. 66, Iss. 2, pp. 270-278
Closed Access | Times Cited: 10
Biological therapy in Psoriasis: An emphasis on its dermatologic adverse events
Pasita Palakornkitti, Kulsupa Nimmannitya, Ploysyne Rattanakaemakorn
Asian Pacific Journal of Allergy and Immunology (2021)
Open Access | Times Cited: 7
A Six-Year Analysis of Biological Therapy for Severe Psoriasis in a Lithuanian Reference Centre of Dermatovenereology
Tadas Raudonis, Akvile Gliebute, Anna Greta Grigaitytė, et al.
Medicina (2020) Vol. 56, Iss. 6, pp. 275-275
Open Access | Times Cited: 4
Interleukin 23 versus interleukin 12/23 inhibitors on preventing incidental psoriatic arthritis in patients with psoriasis? A real-world comparison from the TriNetX Global Collaborative Network
Sung Huang Laurent Tsai, Chi‐Ya Yang, An‐Ping Huo, et al.
Journal of the American Academy of Dermatology (2024) Vol. 91, Iss. 5, pp. 889-895
Closed Access
Psoriasis and malignancy, is there a link? Data from the Malaysian Psoriasis Registry
Mazliha Mashor, Gary Chan, Suganthy Robinson, et al.
(2024) Vol. 52, Iss. 2, pp. 40-48
Closed Access
Page 1 - Next Page

Scroll to top